Last €62.06 EUR
Change Today +0.90 / 1.47%
Volume 10.0K
As of 11:35 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

boiron sa (BOI) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/14 - €64.50
52 Week Low
06/7/13 - €36.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BOIRON SA (BOI)

Related News

No related news articles were found.

boiron sa (BOI) Related Businessweek News

No Related Businessweek News Found

boiron sa (BOI) Details

Boiron SA, a pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and marketing of nonproprietary homeopathic medicines and OTC medication specialties. It offers homeopathic medicines in two family groups, including medicines associated with precise therapeutic indications and dosage in the form of tablets, syrups, single-dose liquids, ointments, and other presentations; and medicines that do not mention a therapeutic indication or dosage in the form of tubes, granular tubes, and cellular doses. The company produces its medicines by using vegetable, animal, mineral, and chemical substances. It primarily operates in France, rest of Europe, and North America. Boiron SA was founded in 1932 and is headquartered in Sainte-Foy-les-Lyon, France.

3,007 Employees
Last Reported Date: 04/7/14
Founded in 1932

boiron sa (BOI) Top Compensated Officers

Chief Pharmacist, Director of Production & Di...
Total Annual Compensation: €341.1K
General Manager and Director
Total Annual Compensation: €608.5K
Director of Development & Research and Deputy...
Total Annual Compensation: €331.0K
Compensation as of Fiscal Year 2012.

boiron sa (BOI) Key Developments

Boiron Announces Resignation of Philippe Montant from His Functions of Deputy General Manager

Boiron announced that Philippe Montant has resigned from his functions of Deputy General Manager.

Boiron Reports Group Earnings Results for the Year Ended December 31, 2013

Boiron reported group earnings results for the year ended December 31, 2013. For the year, the company's sales were EUR 617,731,000 compared to EUR 566,294,000 a year ago. Operating income was EUR 134,306,000 compared to EUR 85,584,000 a year ago. Net income - Group share was EUR 82,396,000 compared to EUR 50,296,000 a year ago. Cash flow was EUR 164,310,000 compared to EUR 114,736,000 a year ago. Tangible and intangible net gross investments were EUR 24,236,000 compared to EUR 19,135,000 a year ago.

Boiron SA, Board Meeting, Mar 19, 2014

Boiron SA, Board Meeting, Mar 19, 2014. Agenda: To consider consolidated financial statements of the financial year ended on December 31, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOI:FP €62.06 EUR +0.90

BOI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOI.
View Industry Companies

Industry Analysis


Industry Average

Valuation BOI Industry Range
Price/Earnings 14.5x
Price/Sales 1.9x
Price/Book 3.0x
Price/Cash Flow 14.5x
TEV/Sales 1.7x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOIRON SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at